Piekos Brian 4
4 · Gemini Therapeutics, Inc. /DE · Filed May 18, 2021
Insider Transaction Report
Form 4
Piekos Brian
Chief Financial Officer
Transactions
- Purchase
Common Stock
2021-05-14$9.46/sh+7,655$72,432→ 7,655 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $9.30 to $9.50. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request.